Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -148,876 | -72,398 | -35,876 | -20,672 | -10,290 |
| Depreciation Amortization | 205 | 605 | 408 | 30 | N/A |
| Accounts payable and accrued liabilities | 2,935 | 792 | 30 | 18 | 221 |
| Other Working Capital | 237,012 | 12,515 | -868 | -102 | 382 |
| Other Operating Activity | 16,487 | 7,168 | 6,124 | 3,031 | 6,893 |
| Operating Cash Flow | $107,763 | $-51,318 | $-30,182 | $-17,695 | $-2,794 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -373,372 | -26,252 | -17,084 | -69,066 | N/A |
| PPE Investments | -789 | -237 | -93 | -14 | N/A |
| Investing Cash Flow | $-374,161 | $-26,489 | $-17,177 | $-69,080 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 378,047 | 40,006 | 71,606 | 74,331 | 1 |
| Other Financing Activity | 0 | 0 | 0 | 41,380 | 17,787 |
| Financing Cash Flow | $378,047 | $40,006 | $71,606 | $115,711 | $17,788 |
| Beginning Cash Position | 30,376 | 68,177 | 43,930 | 14,994 | N/A |
| End Cash Position | 142,025 | 30,376 | 68,177 | 43,930 | 14,994 |
| Net Cash Flow | $111,649 | $-37,801 | $24,247 | $28,936 | $14,994 |
| Free Cash Flow | |||||
| Operating Cash Flow | 107,763 | -51,318 | -30,182 | -17,695 | -2,794 |
| Capital Expenditure | -789 | -237 | -93 | -14 | N/A |
| Free Cash Flow | 106,974 | -51,555 | -30,275 | -17,709 | -2,794 |